Treatment of non-Hodgkin's lymphoma in the elderly: an update.
Hematol Oncol
; 16(1): 1-13, 1998 Mar.
Article
en En
| MEDLINE
| ID: mdl-9821407
ABSTRACT
Recent studies specifically directed toward assessing the outcome of older patients with non-Hodgkin's lymphoma (NHL) indicate that age per se is an important and independent prognostic factor for response and survival. We report a review of the clinical trials of the literature and the Aviano Group experience in the treatment of NHL in the elderly. Prospective studies have addressed therapeutic approaches in these patients. Direct comparison of trial results is difficult since different age limits were set for the inclusion of patients under study. These studies suggest that older patients with aggressive NHL should be treated with curative intent.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Linfoma no Hodgkin
Tipo de estudio:
Observational_studies
/
Prognostic_studies
Límite:
Aged
/
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
Hematol Oncol
Año:
1998
Tipo del documento:
Article
País de afiliación:
Italia